DBP B — Double Bond Pharmaceutical International AB (publ) Cashflow Statement
0.000.00%
Last trade - 00:00- SEK26.34m
- SEK25.05m
- SEK0.08m
Annual cashflow statement for Double Bond Pharmaceutical International AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | SAS | SAS | SAS | SAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -9.26 | -15.2 | -17.3 | -7.11 | -0.333 |
| Depreciation | |||||
| Non-Cash Items | -10 | 0 | 8.53 | 5.42 | 0.591 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.953 | 1.61 | 5.74 | 1.58 | -7.14 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -20 | -13.4 | -3.08 | -0.114 | -6.88 |
| Capital Expenditures | -0.326 | 0 | — | -6.13 | -6.36 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 1.67 | 0 | -6.21 | 0.545 | 0 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Cash from Investing Activities | 1.34 | 0 | -6.21 | -5.59 | -6.36 |
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 15.9 | 3.34 | 10.6 | 5.76 | 10.5 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -2.83 | -10 | 1.33 | 0.059 | -2.7 |